The 6th Rare & Genetic Kidney Disease Drug Development Summit is your unique forum to learn, network and partner with the brightest minds revolutionizing the industry.
Here’s a preview of what’s inside:
3 Days of Insights from Leading Renal Innovators
Hear how organizations, including Takeda, Maze Therapeutics, and Walden Biosciences, are refining strategies, prioritizing assets, and staying ahead in rare kidney disease development.
6+ Hours of Dedicated Networking Sessions
Through interactive roundtables, dedicated networking sessions, and engaging poster sessions, see how the summit can support you in building the industry partnerships required to progress your drug development pipeline.
5+ Key Disease Indications Covered
Explore comprehensive coverage of IgAN, FSGS, ADPKD, Alport syndrome, and C3G, with tailored insights into the unique developmental challenges in each.
Download Your Copy of the Agenda
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Attending Companies Include
